COMP <GO>
HSIC vs JNJ // FORWARD P/E MULTIPLE
Henry Schein Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: HSIC 3
— JNJ 11
▲ FORWARD P/E MULTIPLE LEADER: HSIC
LAST: $84.88 (-1.80%) • MKT CAP: $9.63B
forward-pe
21.4x
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
forward-pe
23.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSIC VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSIC | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.10% | 67.90% | -36.80 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.20% | 25.50% | -14.30 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.5x | 18.5x | -9.00 | HSIC | /valuation <GO> |
| Free Cash Flow Yield | 1.23% | 2.97% | -1.74 | JNJ | /fcf-yield <GO> |
| Operating Margin | 5.00% | 34.70% | -29.70 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 28.50% | -25.30 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 4.00% | 6.00% | -2.00 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.81 | 5.59 | -2.78 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 7.20% | -0.70 | HSIC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.8 | 60.4 | -12.55 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.89 | 1.08 | -0.19 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 21.4x | 23.0x | -1.60 | HSIC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.63B | $662.49B | -$652.86B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSIC REV | JNJ REV | HSIC GROSS % | JNJ GROSS % | HSIC FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.18B | $94.19B | 31.1% | 67.9% | $118.7M | $19.70B |
| FY 2024 | $12.67B | $88.82B | 31.7% | 69.1% | $277.7M | $19.84B |
| FY 2023 | $12.34B | $85.16B | 44.0% | 44.0% | -$55.3M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSIC // BETA 0.89
JNJ // BETA 1.08